Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Rebound or retention: A meta-analysis of weight regain after the discontinuation of glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity drugs
March 5, 2024 Live Updates: Tracking Insurance Coverage for GIP and GLP-1 Agonists Like Zepbound and Wegovy GoodRx
Value investors probably won't find the stock interesting, but growth investors shouldn't ignore it because of its lofty P/E ratio
GLP-1
US$ 26.50
US$ 28.02
US$ 27.08
US$ 27.04
US$ 21.81
US$ 23.19
US$ 22.06
US$ 23.54
US$ 29.20
US$ 27.36
